Scholarlink

<p>Light activation of photosensitizers, including verteporfin–conjugates entrapped in liposomes, can induce photochemical immunogenic cell death (ICD) in cancer cells by exposing damage-associated molecular patterns (DAMPs) under specific conditions. In this study, we investigated how incorporation of the clinical ionizable lipid SM-102 into light-activated liposomes containing the verteporfin–conjugate 20:0 BPD-PC effects key photochemical and photobiological attributes we previously identified to be strongly associated with photochemical ICD. We show that SM-102 incorporation increases the ratio of Type I (hydroxyl radical and peroxynitrite anion)-to-Type II (singlet oxygen) reactive oxygen species by ~ 2.5-fold, increases mitochondrial localization, and improves CT1BA5 mouse pancreatic cancer cell uptake by&#xa0;7-fold and phototoxicity by 10-fold. These result in more potent photochemical ICD responses with up to 8-fold increases in the exposure of the DAMPs calreticulin, HSP-70, and HMGB1 following 690&#xa0;nm light activation. In an immune-cold syngeneic mouse PDAC model, 690&#xa0;nm light activation of SM-102-containing liposomes slowed tumor growth by up to 56% and extended survival by 40%. Together, these findings suggest that integrating SM-102 into light-activated liposomes is a simple and robust strategy to enhance photochemical ICD and may improve therapeutic outcomes in immunotherapy-based combinations that utilize liposomal drug delivery systems.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The clinical ionizable lipid SM-102 enhances photochemical immunogenic cell death by verteporfin-conjugated liposomes and improves survival in vivo

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月12日

查看全文
  • Nimit Shah,
  • Maxwell Bortei Quaye,
  • Bhavana Sudula,
  • Nikita Kulkarni,
  • Aarati Upreti,
  • Ashritha Malkoochi,
  • Taksheel Rao Aileni,
  • Kunal Karambelkar,
  • Arden Peterson,
  • Doha Mahmoud,
  • Meghana Sree Vadlamudi,
  • Siddharth Reddy Soma,
  • Caroline N. Jones,
  • Rolf A. Brekken,
  • Girgis Obaid

摘要

Light activation of photosensitizers, including verteporfin–conjugates entrapped in liposomes, can induce photochemical immunogenic cell death (ICD) in cancer cells by exposing damage-associated molecular patterns (DAMPs) under specific conditions. In this study, we investigated how incorporation of the clinical ionizable lipid SM-102 into light-activated liposomes containing the verteporfin–conjugate 20:0 BPD-PC effects key photochemical and photobiological attributes we previously identified to be strongly associated with photochemical ICD. We show that SM-102 incorporation increases the ratio of Type I (hydroxyl radical and peroxynitrite anion)-to-Type II (singlet oxygen) reactive oxygen species by ~ 2.5-fold, increases mitochondrial localization, and improves CT1BA5 mouse pancreatic cancer cell uptake by 7-fold and phototoxicity by 10-fold. These result in more potent photochemical ICD responses with up to 8-fold increases in the exposure of the DAMPs calreticulin, HSP-70, and HMGB1 following 690 nm light activation. In an immune-cold syngeneic mouse PDAC model, 690 nm light activation of SM-102-containing liposomes slowed tumor growth by up to 56% and extended survival by 40%. Together, these findings suggest that integrating SM-102 into light-activated liposomes is a simple and robust strategy to enhance photochemical ICD and may improve therapeutic outcomes in immunotherapy-based combinations that utilize liposomal drug delivery systems.